Remove Bioavailability Remove Biohazard Remove Drugs
article thumbnail

Nanomilling: How the latest Dynamic Light Scattering (DLS) technology could revolutionise hydrophobic API production

Pharmaceutical Technology

However, stopping nucleation and growth is challenging and often involves the use of biohazardous substances. The paper concludes by noting that the potential cost reductions generated in the production of highly bioavailable APIs, as well as improved quality control, can ultimately promote production of custom formulations.